Skip to content

PHIBRO ANIMAL HEALTH CORP

PAHC

CIK 0001069899

← back to feed
Revenue (TTM)
$1.47B
+27.4% YoY Q3 Mar 2026
Net Income (TTM)
$98.89M
+1,897.7% YoY Q3 Mar 2026
EPS Diluted (TTM)
$2.42
+1,883.3% YoY Q3 Mar 2026
Gross Margin
32.9%
Q3 Mar 2026
Operating Margin
12.2%
Q3 Mar 2026
Net Margin
6.7%
Q3 Mar 2026
Free Cash Flow (TTM)
−$26.62M
Q3 Mar 2026
Cash
$54.93M
Q3 Mar 2026
Total Debt
$599.58M
Q3 Mar 2026
Shares Outstanding
68.91M sh
Q3 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings